In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer
出版年份 2018 全文链接
标题
In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer
作者
关键词
-
出版物
Nature Communications
Volume 9, Issue 1, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-08-23
DOI
10.1038/s41467-018-05742-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer
- (2016) Justin M. Drake et al. CELL
- Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
- (2016) Hui Zhang et al. CELL
- Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development
- (2016) James F. Blake et al. JOURNAL OF MEDICINAL CHEMISTRY
- Proteogenomics connects somatic mutations to signalling in breast cancer
- (2016) Philipp Mertins et al. NATURE
- Landscape of somatic mutations in 560 breast cancer whole-genome sequences
- (2016) Serena Nik-Zainal et al. NATURE
- PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression
- (2016) Dai Horiuchi et al. NATURE MEDICINE
- PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer
- (2016) Fara Brasó-Maristany et al. NATURE MEDICINE
- Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
- (2016) Maxim V. Kuleshov et al. NUCLEIC ACIDS RESEARCH
- COSMIC: somatic cancer genetics at high-resolution
- (2016) Simon A. Forbes et al. NUCLEIC ACIDS RESEARCH
- In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype
- (2016) D. Bossi et al. Cancer Discovery
- Phosphoproteomics in the Age of Rapid and Deep Proteome Profiling
- (2015) Nicholas M. Riley et al. ANALYTICAL CHEMISTRY
- Current strategies and findings in clinically relevant post-translational modification-specific proteomics
- (2015) Oliver Pagel et al. Expert Review of Proteomics
- Critical roles of specimen type and temperature before and during fixation in the detection of phosphoproteins in breast cancer tissues
- (2015) Sibylle Gündisch et al. LABORATORY INVESTIGATION
- High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
- (2015) Hui Gao et al. NATURE MEDICINE
- 2016 update of the PRIDE database and its related tools
- (2015) Juan Antonio Vizcaíno et al. NUCLEIC ACIDS RESEARCH
- ClinVar: public archive of interpretations of clinically relevant variants
- (2015) Melissa J. Landrum et al. NUCLEIC ACIDS RESEARCH
- The Proteomic Landscape of Triple-Negative Breast Cancer
- (2015) Robert T. Lawrence et al. Cell Reports
- Definition of PKC-α, CDK6, and MET as Therapeutic Targets in Triple-Negative Breast Cancer
- (2014) Yi-Hsin Hsu et al. CANCER RESEARCH
- Predicting Cancer-Specific Vulnerability via Data-Driven Detection of Synthetic Lethality
- (2014) Livnat Jerby-Arnon et al. CELL
- Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
- (2014) M. D. Burstein et al. CLINICAL CANCER RESEARCH
- A phase I trial of LY2584702 tosylate, a p70 S6 kinase inhibitor, in patients with advanced solid tumours
- (2014) Anthony Tolcher et al. EUROPEAN JOURNAL OF CANCER
- Single-step Enrichment by Ti4+-IMAC and Label-free Quantitation Enables In-depth Monitoring of Phosphorylation Dynamics with High Reproducibility and Temporal Resolution
- (2014) Erik L. de Graaf et al. MOLECULAR & CELLULAR PROTEOMICS
- Ischemia in Tumors Induces Early and Sustained Phosphorylation Changes in Stress Kinase Pathways but Does Not Affect Global Protein Levels
- (2014) Philipp Mertins et al. MOLECULAR & CELLULAR PROTEOMICS
- A draft map of the human proteome
- (2014) Min-Sik Kim et al. NATURE
- RUbioSeq: a suite of parallelized pipelines to automate exome variation and bisulfite-seq analyses
- (2013) M. Rubio-Camarillo et al. BIOINFORMATICS
- c-Kit expression as a prognostic molecular marker in patients with basal-like breast cancer
- (2013) S. Kashiwagi et al. BRITISH JOURNAL OF SURGERY
- The CDK1 inhibitor RO3306 improves the response of BRCA-proficient breast cancer cells to PARP inhibition
- (2013) QING XIA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
- (2013) Kristian Cibulskis et al. NATURE BIOTECHNOLOGY
- Robust phosphoproteome enrichment using monodisperse microsphere–based immobilized titanium (IV) ion affinity chromatography
- (2013) Houjiang Zhou et al. Nature Protocols
- p120 catenin is a key effector of a Ras-PKCɛ oncogenic signaling axis
- (2013) S G Dann et al. ONCOGENE
- Applications of mass spectrometry for quantitative protein analysis in formalin-fixed paraffin-embedded tissues
- (2013) Carine Steiner et al. PROTEOMICS
- Defining the expressed breast cancer kinome
- (2012) Alicia A Midland et al. CELL RESEARCH
- Modification of the DNA Damage Response by Therapeutic CDK4/6 Inhibition
- (2012) Jeffry L. Dean et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models
- (2012) Cynthia X. Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- The landscape of cancer genes and mutational processes in breast cancer
- (2012) Philip J. Stephens et al. NATURE
- The clonal and mutational evolution spectrum of primary triple-negative breast cancers
- (2012) Sohrab P. Shah et al. NATURE
- Whole-genome analysis informs breast cancer response to aromatase inhibition
- (2012) Matthew J. Ellis et al. NATURE
- Sequence analysis of mutations and translocations across breast cancer subtypes
- (2012) Shantanu Banerji et al. NATURE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- Next-generation proteomics: towards an integrative view of proteome dynamics
- (2012) A. F. Maarten Altelaar et al. NATURE REVIEWS GENETICS
- Quantitative phosphoproteomics strategies for understanding protein kinase-mediated signal transduction pathways
- (2011) Hidetaka Kosako et al. Expert Review of Proteomics
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Improved Peptide Identification by Targeted Fragmentation Using CID, HCD and ETD on an LTQ-Orbitrap Velos
- (2011) Christian K. Frese et al. JOURNAL OF PROTEOME RESEARCH
- Enhancing the Identification of Phosphopeptides from Putative Basophilic Kinase Substrates Using Ti (IV) Based IMAC Enrichment
- (2011) Houjiang Zhou et al. MOLECULAR & CELLULAR PROTEOMICS
- Proteins kinase Cɛ is required for non-small cell lung carcinoma growth and regulates the expression of apoptotic genes
- (2011) M C Caino et al. ONCOGENE
- Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor
- (2010) William McLaren et al. BIOINFORMATICS
- Selection of extreme phenotypes: the role of clinical observation in translational research
- (2010) José Luis Pérez-Gracia et al. Clinical & Translational Oncology
- Post-translational modifications in signal integration
- (2010) Yonathan Lissanu Deribe et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of a Small Molecule Inhibitor of the Human DNA Repair Enzyme Polynucleotide Kinase/Phosphatase
- (2009) G. K. Freschauf et al. CANCER RESEARCH
- Identification of Novel Kinase Targets for the Treatment of Estrogen Receptor-Negative Breast Cancer
- (2009) C. Speers et al. CLINICAL CANCER RESEARCH
- Universal sample preparation method for proteome analysis
- (2009) Jacek R Wiśniewski et al. NATURE METHODS
- Analytical strategies for phosphoproteomics
- (2009) Tine E. Thingholm et al. PROTEOMICS
- Imatinib mesylate (Gleevec(R)) in advanced breast cancer-expressing C-Kit or PDGFR- : clinical activity and biological correlations
- (2008) M. Cristofanilli et al. ANNALS OF ONCOLOGY
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
- (2008) Jürgen Cox et al. NATURE BIOTECHNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now